在晚期心力衰竭中进行心脏磁共振
Francesca Coraducci1, Giulia De Zan2, Damiano Fedele3,4
1Marche Polytechnic University, Ancona, Italy.
Echocardiography (Mount Kisco, N.Y.)
|June 5, 2024
概括
心脏磁共振 (CMR) 通过协助诊断,预后和治疗计划,有助于管理晚期心力衰竭 (HF). 这次审查强调了CMR的重点.
科学领域:
- 心脏病学 心脏病学
- 医疗成像医学成像
背景情况:
- 晚期心力衰竭 (HF) 提出了复杂的管理挑战,往往导致推迟专家转诊和较差的结果.
- 传统疗法在晚期HF阶段变得不足,需要先进的治疗策略.
研究的目的:
- 审查心磁共振 (CMR) 在高级心力衰竭 (HF) 管理中的综合作用.
- 为了证明CMR在整个患者护理途径中对高级HF的实用性.
主要方法:
- 对心脏磁共振 (CMR) 应用在晚期心力衰竭 (HF) 中现有的文献的综述.
- 讨论CMR在诊断,预后分层,血液动力学评估以及指导心脏移植等先进疗法的作用.
主要成果:
- 心脏磁共振 (CMR) 在高级心力衰竭 (HF) 中对诊断,预后和血液动力学评估有价值.
- CMR支持从初始诊断到随访和考虑先进疗法 (包括心脏移植) 的患者管理.
结论:
- 心脏磁共振 (CMR) 是优化高级心力衰竭 (HF) 患者管理的重要工具.
- 用设备扫描高级HF患者时应对技术挑战对于有效的CMR利用至关重要.
更多相关视频
06:29Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
10.3K
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
9.9K
相关概念视频
Magnetic Resonance Imaging
5.1K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
5.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
